Experimental genetic techniques may one day provide plastic and reconstructive surgeons with an invaluable tool-the Regenerative medicine, a paragon of future healthcare, holds unprecedented potential in extending the reach of treatment modalities for individuals across diseases and lifespan. Emerging regenerative technologies, focused on structural repair and functional restoration, signal a radical transformation in medical and surgical practice. Regenerative medicine is poised to provide innovative solutions in addressing major unmet needs for patients, ranging from congenital disease and trauma to degenerative conditions. Realization of the regenerative model of care predicates a stringent interdisciplinary paradigm that will drive validated science into standardized clinical options. Designed as a a catalyst in advancing rigorous new knowledge on disease causes and cures into informed delivery of quality care, the Mayo Clinic regenerative medicine blueprint offers a patient-centered, team-based strategy that optimizes the discovery–translation–application roadmap for the express purpose of science-supported practice advancement.
Terzic A1, Harper CM Jr, Gores GJ, Pfenning MA. – Abstract – PMID: 24304070 [PubMed – in process]
Read full article: http://online.liebertpub.com/doi/full/10.1089/scd.2013.0448